(Q41207409)

28 September 2017

Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines (English)

1 reference

28 September 2017

1 reference

neoplastic invasiveness

1 reference

Hirata M

1

1 reference

28 September 2017

Itoh M

2

1 reference

28 September 2017

Tsuchida A

3

1 reference

28 September 2017

Ooishi H

4

1 reference

28 September 2017

Hanada K

5

1 reference

28 September 2017

Kajiyama G

6

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

28 September 2017

1 reference

28 September 2017

383

1 reference

28 September 2017

3

1 reference

28 September 2017

241-244

1 reference

Type IV collagenases in tumor invasion and metastasis

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900245-1

Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900245-1

Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900245-1

Growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900245-1

Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900245-1

72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900245-1

Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900245-1

Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900245-1

Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900245-1

10.1016/0014-5793(96)00245-1

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference